Emergent BioSolutions Inc. — Director's Dealing 2020

Mar 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-02-27

Reporting Person: Bailey Sue (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-27	Common Stock	S	6572	$56.9282	Disposed	39761	Direct

Footnotes

F1: Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan, as amended.

F2: The price reported is the weighted average sale price. These shares were sold in multiple transactions in prices ranging from $56.50 to $57.49.